Enveric BiosciencesENVB
13F holders, Q2 2026 (June 30)1holders −10
1new positions
0sold out
$1.38avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Enveric Biosciences Inc. (ENVB) in their 13F filings, down 10 from Q3 2025. 1 opened new positions and 0 sold out. The largest holder was Farther Finance Advisors, LLC ($4K).
- Company
- Enveric Biosciences Inc.
- CUSIP
- 29405E406
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $4K |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q2 2026: 3,000 shares bought, net +3,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Farther Finance Advisors, LLC | 0.00% | New | 3,000 | $4K |
"% of holder's portfolio" is ENVB's weight in each manager's 13F, not the share of Enveric Biosciences Inc. the manager owns.